California Table Grape Commission Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2015
NCT02542176
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

California Table Grape Commission

Active Ingredients

Drugs in Phase 2 Trials (1)

vitis vinifera (6 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cognitive Dysfunction (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 1